Online ISSN 2313-1519
Print    ISSN 1812-2892
Abstract - Risk factors of chronic noncommunicable diseases comorbidity in South-Kazakhstan region
Saule Urazalina, Aisulu Musagalieva, Assel Issabekova, Kulzida Koshumbayeva, Bagdat Akhit


Aim: To conduct a one-stage multicenter study in South-Kazakhstan Region to obtain baseline prevalence of comorbidity of chronic noninfectious diseases and their risk factors.

Material and methods: 1400 persons at the age of 18-69, living in the South-Kazakhstan region. Epidemiological part consisted of: interviewing, physical examination and laboratory tests. For statistical analysis were used MSAccess and SPSS22.0. computer programs.

Results: 12.7% of respondents in South-Kazakhstan region smoke, which statistically significantly less than number of nonsmoking (87.3%; p<0.01) ones. The number of alcohol drinkers is 28.4%, which also less than number of nondrinkers (71.6%; p<0.01). The 48.3% of people included in the study had physical inactivity, while 51.7% had sufficient physical activity.

More than half of respondents had abdominal obesity (67.9%), which higher than number of people without obesity (32.1%; p<0.01). The 72.1% had chronic noninfectious diseases (1009 of 1400). Comorbidity with two diseases – 48.2% (676 of 1400). Most common disease was arterial hypertension (45.9%: 464 of 1009). Less common – chronic kidney disease (2.4%:24 of 1009). The most common comorbidity – arterial hypertension and diabetes mellitus (72.3%). The less common – obesity and chronic obstructive pulmonary diseases (2.3%).

Conclusions: 1. The most common risk factors of chronic noninfectious diseases in South-Kazakhstan region are improper diet, obesity, physical inactivity.

2. The frequency of chronic noninfectious diseases in South-Kazakhstan region was 72.1%. And the most common disease was arterial hypertension.

3. The most common comorbidity – combination diabetes mellitus with arterial hypertension while the less common – combination obesity with chronic obstructive pulmonary disease.

Key words: comorbidity, epidemiology, risk factors, chronic noninfectious diseases


Corresponding Author: Saule Urazalina, MD, PhD, Professor at the Cardiology Unit, Postgraduate Education Department, Scientific-Research Institute of Cardiology and Internal Diseases, Almaty, Republic of Kazakhstan. Tel.: 8 7772446090




  1. Review of social determinants and the health divide in the WHO European regions: final report. Copenhagen: WHO; 2013.188.
  2. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: WHO; 2013. 102.
  3. Wilkinson R., Marmot M. Social determinants of health.  The solid facts (2nd Ed). Geneva: WHO; 2003. 32.
  4. Statisticheskij sbornik Republic of Kazakhstan in 2016 [in Russian]. Astana; 2017. 144.
  5. State program of public health development “Densaulyk” for the period 2016-2020. Order of President of RK from 01.02.2010.№922. [In Russian].

  1. Katsaga A, Kulzhanov M, Karanikolos M, Rechel B. Kazakhstan Health system review. Health Systems in Transition. 2012; 14(4):1-154.
  2. Oganov R.G., Denisov I.N., Simanenkov V.I., Bakulin I.G., Bakulina N.V., Boldueva S.A.  et al. Comorbidities in practice. Clinical guidelines [in Russian]. Cardiovask.Therapy and Prevention. 2017; 16(6):5-56.
  3. Fortin M., Bravo G., Hudon C., Vanasse A., Lapointe L.  Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med. 2005; 3(3):223-228
  4. Vertkin A.L., Skotnikov A.S. Comorbidity [in Russian]. Lechashyi vrach. 2013; 6:61-67.
  5. Methodics calculation of standart coefficients of birth and mortality [in Russian]. Agency of statistics RK; 2012. 346.
  6. Perk J., De Backer G., Gohlke H., Graham I., Reiner Z., Albus C. et etc. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J.2012; 33:1635-1701
  7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2015; 38 (1):1-S93.
  8. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I, Donato K.A. et etc. Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120:1640-1645.

  1. Shvarts V.Ya. Inflammation of adipose tissue (part 4). Obesity-new infection disease? (review). [in Russian]. Problems of endocrinology. 2011; 5:63-71.
  2. Mancia G., Fagard R., Narkiewicz K., Redon J., Zanchetti A., Bohm M et etc. ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013; 31:1281-1357.
  3.  Bruce S.G., Riediger N.D., Zacharias J.M., Young T.K. Obesity and obesity-related comorbidities in a Canadian First Nation population. Prev. Chronic Dis. 2011; 8(1): A03.
  4. Kukharchuk V.V. Arterial'naya gipertoniya, narusheniya lipidnogo obmena i ateroskleroz. V kn.: Rukovodstvo po arterial'noy gipertonii [Arterial hypertension, lipid disorders and atherosclerosis. In: Guide to an arterial hypertension]. Pod red. Chazova E.I., Chazovoy I.E. [in Russian]. Moscow: Media Medika; 2005. 289-299.
  5.  Cassell A., Edwards D., Harshfield A., Rhodes K., Brimicombe J., Pavne R., Griffin S. The epidemiology of multimorbidity in primary care: a retrospective cohort study. Br. J. Gen. Pract. 2018; 68(669):e245-e251.
  6. Van den Akker M., Buntinx F., Metsemakers J., Roos S., Knottnerus J.A. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J. Clin Epidemiol. 1998; 51(5): 367-375.
  7.  Jadad A.R., To M.J., Emara M., Jones J. Consideration of Multiple Chronic diseases in randomized controlled trials. JAMA. 2011; 306 (24):2670-2672.
  8. Liam G., Reddan D., Newell J., Hinde J., Dinneen S.F., Murphy A.W. Multimorbidity and risk among patients with established cardiovascular disease: a cohort study. Br. J. Gen Pract. 2008; 58(552):488-494.

  1.  Caughey G. E., Vitry A. I., Gilbert A. L., Roughead E. E. Prevalence of comorbidity of chronic diseases in Australia. BMC Public Health. 2008; 8:221.
  2. Schellevis F. G., Velden J., Lisdonk E., Eiik J.T., Weel C. Comorbidity of chronic diseases in general practice. J. Clin. Epidemiol. 1993; 46(5): 469-473.
  3.  Gijsen R., Hoeymans N., Schellevis F.G., Ruwaard D., Satariano W.A. Causes and consequences of comorbidity: a review. J. Clinical Epidemiology. 2001; 54(7): 661-674.
  4.  Dedov I.I. Diabetes mellitus – a dangerous treat to the mankind [in Russian]. Vestnik RAMS. 2012;1(67):7-13.
  5.  Rabe K.F., Hurd S., Anzueto A., Barnes P.J., Buist S.A., Calverley P. et etc. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. Amer.J.Respir. Crit. Care Med.2007; 176(6):532-555.
  6.  Sarnak M.J., Levey A.S., Schoolwerth A.C. , Coresh J., Culleton B., Hamm L.L. et etc. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003; 42(5): 1050-1065.


Volume 1, Number 51 (2019)